REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Sulfur Containing Hetero Ring > The Hetero Ring Is Five-membered The Hetero Ring Is Five-memberedThe Hetero Ring Is Five-membered patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.11/30/06 - 20060270731 - Pure duloxetine hydrochloride Chemically and/or enantiomerically pure duloxetine HCl and process for preparing chemically and/or enantiomerically pure duloxetine HCl are provided. ... 08/31/06 - 20060194869 - Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof Processes for preparing DNT-base, duloxetine alkyl carbamate, duloxetine-base and duloxetine hydrochloride, are provided. Also provided, are processes for converting DNT-base, duloxetine alkyl carbamate and duloxetine-base into pharmaceutically acceptable salts of duloxetine. ... 08/17/06 - 20060183792 - Substituted thienyl and furyl acylguanidines and methods of their use as beta-secretase modulators The present invention also provides methods for the inhibition of β-secretase (BACE) and for the treatment of β-amyloid deposits and neurofibrillary tangles. ... 08/17/06 - 20060183791 - Substituted p-diaminobenzene derivatives The present invention relates to aniline derivatives of the general formula I or pharmaceutically acceptable salts thereof and their use. ... 06/22/06 - 20060135597 - Large conductance calcium-activated k channel opener R1 is aryl, heterocyclic or heterocycle-substituted carbonyl; R2 is hydrogen, halogen, carboxy, amino, alkyl, alkoxycarbonyl, alkenyl or cycloalkyl; R3 is aryl, heterocyclic or alkyl; and R4 is hydrogen or alkyl, each of substituents may be substituted, or a pharmaceutically acceptable salt thereof as an active ingredient. ... 06/08/06 - 20060122256 - Biaryloxymethylarenecarboxylic acids as glycogen synthase activators wherein Ar, Ar2, R2, R3, R4, m, p and s are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases that are associated with the activation of the glycogen synthase enzyme, such as diabetes. ... 04/13/06 - 20060079569 - Antidepressant oral liquid compositions The invention provides for the first time an oral liquid composition of duloxetine or its pharmaceutically equivalent derivatives like salts, isomers, complexes, polymorphs, hydrates or esters thereof. The duloxetine or its pharmaceutically equivalent derivative is present from about 2 mg to approximately 200 mg; and a buffering agent was used ... 03/23/06 - 20060063828 - 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof or its pharmaceutically acceptable salt or ester, wherein the substituents are defined in the application. ... 02/16/06 - 20060035961 - Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents wherein A, B, R1, R2, D, and E are defined herein. Use of the diseases for the treatment of diseases, and compositions and medicaments related thereto are also disclosed. ... 02/16/06 - 20060035960 - Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents or derivatives thereof, or pharmaceutically acceptable salts, tetrazoles, or prodrugs of compounds of the structure or derivatives thereof, said derivatives being described in detail herein. Also disclosed herein are methods of treating diseases or conditions, including glaucoma and elevated intraocular pressure. Compositions and methods of manufacturing medicaments related thereto are ... 02/02/06 - 20060025472 - Fungicidal carboxamides and R3-R11 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula I and a method for controlling plant diseases caused by fungal plant pathogens which involves applying an effective amount of a compound of Formula I. ... 01/26/06 - 20060020019 - Aryloxyalkylamine nk-1/ssri inhibitors The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts and solvates, their pharmaceutical compositions, and their use in treating disorders associated with an excess or imbalance of tachykinins or serotonin or both. ... 01/19/06 - 20060014822 - 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system The present invention concerns 1,2,4-triaminobenzene derivatives of the general formula I or pharmaceutically acceptable salts thereof and the use thereof. ... 12/08/05 - 20050272805 - Treatment of gastrointestinal disorders with duloxetine The present invention belongs to the fields of medicinal and pharmaceutical chemistry, and provides a new method of treating gastrointestinal disorders by the administration of duloxetine. ... 09/08/05 - 20050197385 - Use of rotigotine for treatment or prevention of dopaminergic neuron loss The present patent application relates to the use of Rotigotine or its salts and prodrugs for preparation of a drug for treatment or prophylaxis of dopaminergic cell loss due to diseases that are connected with an increased dopaminergic cell loss. In particular, the patent application is related to the use ... 08/18/05 - 20050182127 - N-acylaminoacetonitrile derivatives and their use for controlling parasites in which R1, R2, R3, R4, R5, R6, W, X, A1, A2, a, b and c are as defined in the specification, and to any enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are particularly suitable for controlling parasites in warm-blooded animals. ... ### FreshPatents.com Support |